Canada tender · Request for Proposal
Pralidoxime
Reference number: w6369-26-a033
Published: 2025-12-01
Closing date: 2026-01-22
Tender details
The Department of National Defence requires the supply of Pralidoxime, a critical medication for treating Canadian Armed Forces members exposed to chemical warfare agents. The initial order is for 1,025 doses by March 31, 2026, with an option for an additional 4,100 doses between April 2026 and March 2030. This opportunity is essential for ensuring the health and safety of military personnel, making it a vital contract for suppliers in the pharmaceutical sector.